)
)
Amarin Corporation Investor Relations Material
Latest events
CMD 2024
Amarin Corporation
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Amarin Corporation plc
Access all reports
Amarin Corporation plc is a biopharmaceutical company focused on developing and commercializing therapies for cardiovascular health. The company's primary product is an omega-3-based prescription therapy designed to reduce cardiovascular risk in patients with elevated triglyceride levels. Amarin's research and development efforts center on addressing unmet needs in cardiovascular care through innovative lipid management treatments. The company operates globally, with a focus on expanding its product offerings and advancing cardiovascular treatment options. The company is headquartered in Dublin, Ireland, and its shares are listed on the Nasdaq.
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
AMRN
Country
🇺🇸 United States